课题基金 / 基金详情

Research Education About Cancer and Health (REACH) Core

Research Education About Cancer and Health (REACH) Core
关于癌症与健康的研究教育 (REACH) 核心
批准号:
10756839
负责人:
Julian A Simon
金额:
$16.57万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-09-30 至 2028-08-31

项目摘要

项目成果

Julian A Simon的其他基金

相关文献

中文摘要
翻译
摘要 关于癌症和健康的伙伴关系研究教育(REACH)核心将提供研究 癌症和健康差距的教育活动,并准备未来的科学家, 生物医学研究队伍的多样化。REACH核心已经证明了非凡的成功 培训本科生和研究生,包括来自历史上被排斥的社区的个人 (HEC)在U 54伙伴关系以前的供资周期中。根据其实施各种 研究教育计划,如本科(癌症研究实习NMSU本科生; CRI-U)和研究生(NMSU毕业生癌症研究实习; CRI-G)研究实习, 研究生健康差异课程(华盛顿大学公共卫生学院)和健康 差异实地经验(在U 54-IV中更名为健康公平实地经验),该伙伴关系将 实施以癌症和/或健康为重点的综合生物医学研究教育计划 差异研究,在一系列的学术水平,以多样化的科学劳动力有助于 生物医学和人口健康研究。该伙伴关系还将提供并行和持续的支持 促进所有参与者实现学术和专业目标。形成性评估, 优势和信息领域的研究教育活动的改进将进行与 规划和评估核心。伙伴关系将继续使用长期跟踪工具, 支持参与者并评估活动的影响和有效性。针对过去的方案 内部咨询委员会和外部计划指导的评估和建议 委员会,提出了一系列活动,优先考虑目前的需要,以促进和提高癌症 研究教育,重点是在这两个机构的本科生和研究生。 REACH核心将实施跨学术水平和学科的教育计划; 对于学员的目标实现,确定个人特定的需求和兴趣、机会以及 职业发展的潜在障碍;为学员设计创造社区感的体验 并属于伙伴关系内部和更广泛的科学界,以及; 评估研究教育活动的有效性,包括长期跟踪, 创新的机会和改进的需要,同时满足参与者的各种需求。这些 这些活动将有助于实现伙伴关系的目标,即生物医学劳动力多样化, 包容性和积极的研究环境和增强癌症健康公平性。
英文摘要
ABSTRACT The Partnership Research Education About Cancer and Health (REACH) Core will deliver research education activities in cancer and health disparities and prepare future scientists to contribute to the diversification of the biomedical research workforce. The REACH Core has demonstrated exceptional success in training undergraduate and graduate students, including individuals from Historically Excluded Communities (HECs) in previous U54 Partnership funding cycles. Based on its experience implementing a variety of research education programs such as undergraduate (Cancer Research Internship for NMSU Undergraduates; CRI-U) and graduate (Cancer Research Internship for NMSU Graduates; CRI-G) research internships, Graduate Health Disparities Course (University of Washington, School of Public Health), and the Health Disparities Field Experience (renamed the Health Equity Field Experience in the U54-IV), the Partnership will implement integrated biomedical research education programs with an emphasis on cancer and/or health disparities research, across a spectrum of academic levels to diversify the scientific workforce contributing to biomedical and population health research. The Partnership will also provide concurrent and on-going support for academic and professional goal attainment among all its participants. Formative assessments to measure strengths and inform areas for improvement of research education activities will be carried out with the Planning & Evaluation Core. The Partnership will continue to use long-term tracking tools to offer sustained support to participants and evaluate impact and effectiveness of activities. In response to past program evaluation and recommendations from the Internal Advisory Committee and external Program Steering Committee, a portfolio of activities is proposed that prioritize the current needs to promote and heighten cancer research education that is focused on undergraduate and graduate students at both institutions. The REACH Core will implement education programs across academic levels and disciplines; provide support for trainees’ goal attainment that identifies individual-specific needs and interests, opportunities as well as potential barriers to career advancement; design experiences for trainees that create a sense of community and belonging both within the Partnership and more broadly in the larger scientific community, and; conduct assessments of research education activities’ effectiveness, including long-term tracking, to identify opportunities for innovation and needs for improvement while meeting the diverse needs of participants. These activities will contribute to the Partnership’s Aims of diversifying the biomedical workforce, creating a more inclusive and affirmative research environment and enhancing cancer health equity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
Chemoprotection Against Aminoglycoside-Induced Ototoxicity